Search Results
Results found for "Celtarys partnership"
- How Schild Analysis Protects Your Conclusions in GPCR Research
This conversation is part of a three episode series produced in collaboration with our partners at Celtarys
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
At Celtarys, we support this transition by offering optimized fluorescent ligands specifically designed
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
In Episode 3 of 3 of our series with Celtarys Research , leaders from academia and biotech unpack what
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
This conversation is part of a three episode series produced in collaboration with our partners at Celtarys
- Your GPCR Program Decisions Depend on Good Data Interpretation
GPCR University Learner Celtarys Research Recap: Medicinal Chemistry Highlights You May Have Missed The
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Corner members get to rewatch the recording Subscribe to the Kenakin Brief and Join the Live AMA ➤ Celtarys
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Join Terry's Corner Today ➤ Celtarys Research – Confocal Imaging That Preserves GPCR Function Confocal
- 📰 GPCR Weekly News, September 4 to 10, 2023
Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech Forum Celtarys
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
. 👉 Go behind the scenes with Revvity’s R&D team ➤ Celtarys Research – Advantages of Fluorescent Ligands
- From GPCR Data Chaos to Decisive Action
True Embedded Partnership I review CRO scopes, flag risks early, and sit in on your strategic calls. My work is rooted in: ✔️ Scientific Integrity ✔️ Operational Discipline ✔️ Collaborative Partnership
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
It took data, yes—but also a deep partnership with GPCR legend Terry Kenakin to bridge industry credibility Eric is clear: real innovation requires real partnerships.
- From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry
Instead of choosing between academia and career, he engineered a third path : a partnership between BMS
- New Podcast, Sweet Structures & $2.2B GPCR Moves
From sugar-sensing structures to strategic partnerships—GPCRs remain at the center of it all.
- The Truth About GPCR Product Launches: Years in the Making
in endogenous cells expressing GLP-1R → Commercial launch of pHSense as a plate-ready assay Real Partnerships Revnity’s partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Her expertise guided numerous global negotiations, conclusions of partnership agreements, and fostered
- GPCR Collaboration: From Models to Medicine
Over time, that transparency has built enduring partnerships , including one of Carlsson’s earliest with These values have become the glue that holds his partnerships together .
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
Richard is the architect behind nearly all of Exscientia's partnerships and collaborations across pharma
- Verily links up with Sosei Heptares for GPCR drug discovery
drug discovery have clocked in at $1 billion—with Genentech—and, just last November, $2.6 billion in a partnership
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
For example, a Cy5-labelled fluorescent ligand with the same pharmacophore is available from Celtarys The Dopamine D3 Receptor, a Quarter Century Later.
- Exscientia is 10 years old this July!
validated to guide treatment selection in patients with advanced haematological cancers, international partnerships
- Accelerating GPCR Drug Discovery
Collaborative Partnership: I embed, contribute, and build solutions hand-in-hand with your team.
- GPCR Happy Hour – Boston, Sept 2025
It’s where partnerships spark, ideas collide, and the GPCR community grows stronger — together.
- Molecular creativity in drug discovery
. • Inclusive Growth : More access for developing nations, new instructors welcome, and global partnerships
- How GPCR Collaboration Built an Innovation Engine
Pooled grants fund expansion and training programs Year 7 — International collaborations and industry partnerships
- Innovative Data-Driven Solutions: The pHSense Revolution
Behind Every Probe Is a Partnership While the final product may arrive neatly packaged, the journey behind
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
They both mark critical moments in humanity’s centuries-long quest to control physiology—and they bookend
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
CRO partnerships are essential for most discovery programs, but they often break down on communication
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Allosterics , in contrast, act more like tuning knobs—modulating receptor ensembles in partnership with
- 📰 GPCR Weekly News, June 3 to June 9, 2024
GPCR Event Highlight We are thrilled to share the news of our in-person event in partnership with the
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Novo Nordisk cuts Ozempic® cost; Nxera launches obesity pipeline; Superluminal–Lilly cardiometabolic partnership

























